The Discovery of YM-60828: A Potent, Selective and Orally-Bioavailable Factor Xa Inhibitor-Reference-Cited by-同舟云学术

The Discovery of YM-60828: A Potent, Selective and Orally-Bioavailable Factor Xa Inhibitor

Published:2002-05 Issue:5 Volume:10 Page:1509-1523
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Hirayama Fukushi,Koshio Hiroyuki,Katayama Naoko,Kurihara Hiroyuki,Taniuchi Yuta,Sato Kazuo,Hisamichi Nami,Sakai-Moritani Yumiko,Kawasaki Tomihisa,Matsumoto Yuzo,Yanagisawa Isao

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference35 articles.

1. Clinically Important Drug Interactions with Anticoagulants

2. Oral Anticoagulant Drugs

3. Interactions of Warfarin with Drugs and Food

4. Direct thrombin inhibitors: current status and future prospects

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. One-Pot Synthesis of Sulfonamides from Unactivated Acids and Amines via Aromatic Decarboxylative Halosulfonylation;Journal of the American Chemical Society;2023-09-20

2. Enantioselective Organocatalytic Synthesis of 1,2,3‐Trisubstituted Cyclopentanes;European Journal of Organic Chemistry;2021-09-24

3. Enantioselective Construction of Spirooxindole-Fused Cyclopentanes;The Journal of Organic Chemistry;2021-07-20

4. A Novel Fragment Recommendation Workflow using Direct and Indirect Transfer of SAR According to Integrated Similarities of Scaffold Motifs and SAR Trends: Application to Identifying Factor Xa Inhibitors;Chem-Bio Informatics Journal;2017

5. Structure–activity relationship studies for multitarget antithrombotic drugs;Future Medicinal Chemistry;2016-12